(Q53537199)

15 May 2018

title

Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. (English)

1 reference

15 May 2018

Peer Carsten Tfelt-Hansen

1 reference

1 reference

series ordinal

5

object named as

P Tfelt-Hansen

1 reference

15 May 2018

3

M Ferrari

1 reference

15 May 2018

4

G Nappi

1 reference

15 May 2018

Hans-Christoph Diener

series ordinal

1

object named as

H C Diener

1 reference

15 May 2018

A J Dowson

2

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

15 May 2018

published in

Cephalalgia

1 reference

15 May 2018

volume

19

1 reference

15 May 2018

issue

8

1 reference

15 May 2018

page(s)

699-700

1 reference

15 May 2018

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008699.X

Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008699.X

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008699.X

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1999.019008699.X

10.1046/J.1468-2982.1999.019008699.X

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018